Company Analysis
Sign in

Mdxhealth Sa (MDXH)

Nasdaq: MDXH · Services-Medical Laboratories · Herstal, BE · filing with the SEC since 2021
Full chart Alerts Compare
Grade5.4
◀ Past 6.1● Present 5.0▶ Future 5.2
2 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart
The companyfiscal 2025, as filed
Revenue$108M+19.8%
Net income-$33.5M+12.0%
Earnings per share$-0.67+42.2%
Operating cash flow-$2.2M+88.2%
Cash$29.0M-38.0%
Debtn/a
Shareholders’ equity-$12.1M-181.5%
Shares, diluted50.0M+52.0%
Return on equityn/a
The recordfrom its filings
Filings in 202649
Newest filingNov 12 · 6-K
Annual reportApr 3, 2026
Quarterly reportn/a
Next report due20-F by Apr 30
Insider sales, 12 months$0.00
Insider buys, 12 months$1.0M
Patents granted11
Filer categoryNon-accelerated filer<br>Emerging growth company
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
Revenue and net income by fiscal yearRevenueNet income
19202122232425
As filed, in USD. Nothing here is a forecast.

News

Aug 17, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Aug 14, 2026 · SEC EDGAR · Form SCHEDULE 13D
Activist holder notice
Open the filing on sec.gov
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.
SI Assistanton MDXH · research, not advice